Reverse Phototherapy With Super Light-emitting Diode(Super-LED) for Hyperbilirubinemia in Term and Late Preterm Infants
NCT ID: NCT01340339
Last Updated: 2011-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
144 participants
INTERVENTIONAL
2010-10-31
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Light-emitting Diodes (LED) Phototherapy for Hyperbilirubinemia of Term Newborn
NCT01136577
Conventional Versus LED Phototherapy and Their Effect on Lymphocytes Subsets of Full Term Neonates With Hyperbilirubinemia
NCT04373980
Comparison of Double Pad Fiber Optic Device Versus Conventional Phototherapy
NCT04585828
Broad Band Emission LED Phototherapy Source Versus Narrow Band
NCT05257369
Aluminum Foil Reflector on Phototherapy for Newborn with Jaundice
NCT06837935
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BILITRON BED®
Super-LED reverse phototherapy
Phototherapy
super LED reverse phototherapy (17 bulbs arranged in 42 x 31 cm in blue base acrylic cot), with spectral irradiance of 8-12microwatts/cm2/nm; daily; until bilirubin reaches level that indicates suspension of therapy
BILIBERÇO®
Fluorescent Reverse Phototherapy
Phototherapy
Fluorescent reverse phototherapy (7 white lights 5cm below the base of acrylic cot), with spectral irradiance of 8-12microwatts/cm2/nm; daily; until bilirubin reaches level that indicates suspension of therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phototherapy
Fluorescent reverse phototherapy (7 white lights 5cm below the base of acrylic cot), with spectral irradiance of 8-12microwatts/cm2/nm; daily; until bilirubin reaches level that indicates suspension of therapy
Phototherapy
super LED reverse phototherapy (17 bulbs arranged in 42 x 31 cm in blue base acrylic cot), with spectral irradiance of 8-12microwatts/cm2/nm; daily; until bilirubin reaches level that indicates suspension of therapy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational age between 350/7 and 416/7 weeks
* Birth weight greater than 2200g
* Absence of congenital malformations
* indication of phototherapy after 48 hours of life
* Terms of consent signed by parent or guardian
Exclusion Criteria
* RH incompatibility hemolytic disease
* Mother's refusal to continue to participate in the study
* Unavailability of the two types of phototherapy equipment for randomization
* Mother or newborn who received phenobarbital
35 Weeks
41 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Professor Fernando Figueira Integral Medicine Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professor Fernando Figueira Integral Medicine Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Danielle Brandão
Role: PRINCIPAL_INVESTIGATOR
Professor Fernando Figueira Medicine Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Danielle Cintra Bezerra Brandão
Recife, Pernambuco, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Brandao DC, Draque CM, Sanudo A, de Gusmao Filho FA, de Almeida MF. LED versus daylight phototherapy at low irradiance in newborns >/=35 weeks of gestation: randomized controlled trial. J Matern Fetal Neonatal Med. 2015;28(14):1725-30. doi: 10.3109/14767058.2014.966678. Epub 2014 Nov 5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FernandoFigueiraIMI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.